Phathom Pharmaceuticals, Inc. SEC filings PHAT

Phathom Pharmaceuticals, Inc. has 495 filings in SEC EDGAR's recent list, going back to Jul 26, 2019. Its latest annual report, Form ARS, was filed on Apr 7, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 29, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 29, 2026 (results of operations). The company's fiscal year ends on December 31.

Phathom Pharmaceuticals, Inc. SEC filings
Form Description Filed Period
SCHEDULE 13D/A Amended ownership over 5% (active) Nov 2, 2026 —
10-Q Quarterly report Oct 29, 2026 Sep 30, 2026
8-K Current report
Results of operations
Oct 29, 2026 Oct 29, 2026
8-K Current report
Other events
Oct 26, 2026 Oct 26, 2026
8-K Current report
Other events
Oct 23, 2026 Oct 23, 2026
4 Insider transaction Oct 8, 2026 Oct 6, 2026
8-K Current report
Other events
Sep 29, 2026 Sep 29, 2026
4 Insider transaction Sep 8, 2026 Sep 3, 2026
10-Q Quarterly report Jul 30, 2026 Jun 30, 2026
8-K Current report
Results of operations
Jul 30, 2026 Jul 30, 2026
SCHEDULE 13G Ownership over 5% (passive) Jul 29, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Jul 20, 2026 —
4 Insider transaction Jul 16, 2026 Jul 14, 2026
8-K Current report
Other events
Jun 23, 2026 Jun 23, 2026
4 Insider transaction May 27, 2026 May 22, 2026
4 Insider transaction May 21, 2026 May 19, 2026
4 Insider transaction May 21, 2026 May 19, 2026
4 Insider transaction May 21, 2026 May 19, 2026
4 Insider transaction May 21, 2026 May 19, 2026
4 Insider transaction May 21, 2026 May 19, 2026
4 Insider transaction May 21, 2026 May 19, 2026
4 Insider transaction May 21, 2026 May 19, 2026
8-K Current report
Shareholder vote results
May 21, 2026 May 19, 2026
10-Q Quarterly report Apr 30, 2026 Mar 31, 2026
8-K Current report
Results of operations
Apr 30, 2026 Apr 30, 2026
DEFA14A Additional proxy material Apr 7, 2026 —
ARS Annual report to shareholders Apr 7, 2026 Dec 31, 2025
DEF 14A Proxy statement Apr 7, 2026 May 19, 2026
S-8 Employee stock plan registration Mar 27, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Mar 12, 2026 —
4 Insider transaction Mar 11, 2026 Mar 10, 2026
4 Insider transaction Mar 3, 2026 Feb 27, 2026
10-K Annual report Feb 26, 2026 Dec 31, 2025
8-K Current report
Results of operations
Feb 26, 2026 Feb 26, 2026
4 Insider transaction Feb 12, 2026 Feb 10, 2026
4 Insider transaction Feb 12, 2026 Feb 10, 2026
4 Insider transaction Jan 27, 2026 Jan 23, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Jan 27, 2026 —
4 Insider transaction Jan 23, 2026 Jan 21, 2026
4 Insider transaction Jan 15, 2026 Jan 13, 2026
8-K Current report
Other events
Jan 8, 2026 Jan 7, 2026
424B5 Prospectus supplement Jan 8, 2026 —
424B5 Prospectus supplement Jan 7, 2026 —
8-K Current report
Results of operations
Jan 7, 2026 Jan 7, 2026
S-3ASR Automatic shelf registration Jan 7, 2026 —
4 Insider transaction Jan 2, 2026 Jan 2, 2026
4 Insider transaction Jan 2, 2026 Jan 2, 2026
4 Insider transaction Jan 2, 2026 Jan 2, 2026
4 Insider transaction Dec 23, 2025 Dec 19, 2025
4 Insider transaction Dec 19, 2025 Dec 18, 2025
4 Insider transaction Dec 19, 2025 Dec 17, 2025
4 Insider transaction Dec 19, 2025 Dec 17, 2025
4 Insider transaction Dec 2, 2025 Nov 28, 2025
4 Insider transaction Nov 5, 2025 Nov 3, 2025
SCHEDULE 13D/A Amended ownership over 5% (active) Nov 4, 2025 —
8-K Current report
Other events
Nov 4, 2025 Nov 4, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 3, 2025 —
10-Q Quarterly report Oct 30, 2025 Sep 30, 2025
8-K Current report
Results of operations
Oct 30, 2025 Oct 30, 2025
8-K Current report
Other events
Oct 27, 2025 Oct 25, 2025
4/A Filing Oct 8, 2025 Oct 6, 2025
4 Insider transaction Oct 7, 2025 Oct 6, 2025
3 Initial insider ownership Oct 7, 2025 Oct 6, 2025
8-K Current report
Officer or director change
Oct 6, 2025 Oct 2, 2025
4 Insider transaction Sep 26, 2025 Sep 25, 2025
4 Insider transaction Sep 9, 2025 Sep 5, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 28, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 25, 2025 —
SCHEDULE 13D/A Amended ownership over 5% (active) Aug 20, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Aug 13, 2025 —
10-Q Quarterly report Aug 7, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 7, 2025 Aug 7, 2025
4 Insider transaction Jul 18, 2025 Jul 16, 2025
4 Insider transaction Jun 24, 2025 Jun 23, 2025
3 Initial insider ownership Jun 24, 2025 Jun 23, 2025
8-K Current report
Other events
Jun 16, 2025 Jun 16, 2025
8-K Current report
Shareholder vote results
Jun 9, 2025 Jun 3, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Jun 9, 2025 —
8-K Current report
Regulation FD disclosure, Other events
Jun 6, 2025 Jun 6, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Jun 6, 2025 —
4 Insider transaction Jun 5, 2025 Jun 3, 2025
4 Insider transaction Jun 5, 2025 Jun 3, 2025
4 Insider transaction Jun 5, 2025 Jun 3, 2025
4 Insider transaction Jun 5, 2025 Jun 3, 2025
4 Insider transaction Jun 5, 2025 Jun 3, 2025
4 Insider transaction Jun 5, 2025 Jun 3, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Jun 4, 2025 —
4 Insider transaction May 23, 2025 May 21, 2025
4 Insider transaction May 21, 2025 May 19, 2025
4 Insider transaction May 15, 2025 May 13, 2025
SCHEDULE 13D/A Amended ownership over 5% (active) May 13, 2025 —
4 Insider transaction May 13, 2025 May 9, 2025
4 Insider transaction May 8, 2025 May 6, 2025
3 Initial insider ownership May 6, 2025 May 1, 2025
10-Q Quarterly report May 1, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 1, 2025 May 1, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Apr 24, 2025 —
ARS Annual report to shareholders Apr 23, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 23, 2025 —
DEF 14A Proxy statement Apr 23, 2025 Jun 3, 2025
4 Insider transaction Apr 16, 2025 Apr 16, 2025
3 Initial insider ownership Apr 16, 2025 Apr 16, 2025
8-K Current report
Officer or director change
Apr 16, 2025 Apr 11, 2025
4 Insider transaction Apr 8, 2025 Apr 7, 2025
4 Insider transaction Apr 3, 2025 Apr 3, 2025
3 Initial insider ownership Apr 3, 2025 Apr 1, 2025
S-8 Employee stock plan registration Apr 3, 2025 —
8-K Current report
Officer or director change
Apr 1, 2025 Mar 31, 2025
4 Insider transaction Mar 21, 2025 Sep 10, 2024
4 Insider transaction Mar 17, 2025 Mar 13, 2025
S-8 Employee stock plan registration Mar 6, 2025 —
8-K Current report
Results of operations
Mar 6, 2025 Mar 6, 2025
10-K Annual report Mar 6, 2025 Dec 31, 2024
4 Insider transaction Mar 3, 2025 Feb 27, 2025
4 Insider transaction Mar 3, 2025 Feb 27, 2025
4 Insider transaction Mar 3, 2025 Feb 27, 2025
4 Insider transaction Jan 23, 2025 Jan 21, 2025
4 Insider transaction Jan 23, 2025 Jan 21, 2025
4 Insider transaction Jan 23, 2025 Jan 21, 2025
4 Insider transaction Dec 20, 2024 Dec 19, 2024
4 Insider transaction Dec 20, 2024 Dec 19, 2024
4 Insider transaction Dec 16, 2024 Dec 13, 2024
4 Insider transaction Dec 16, 2024 Dec 13, 2024
8-K Current report
Other events
Dec 11, 2024 Dec 11, 2024
SC 13G Ownership over 5% (passive) Nov 12, 2024 —
10-Q Quarterly report Nov 7, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 7, 2024 Nov 7, 2024
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 5, 2024 —
SCHEDULE 13G Ownership over 5% (passive) Nov 5, 2024 —
SC 13G Ownership over 5% (passive) Nov 4, 2024 —
SC 13G Ownership over 5% (passive) Oct 21, 2024 —
SC 13D/A Amended ownership over 5% (active) Aug 22, 2024 —
8-K Current report
Other events
Aug 19, 2024 Aug 19, 2024
424B5 Prospectus supplement Aug 19, 2024 —
FWP Free writing prospectus Aug 19, 2024 —
10-Q Quarterly report Aug 8, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 8, 2024 Aug 8, 2024
8-K Current report
Other events
Jul 18, 2024 Jul 18, 2024
4 Insider transaction Jul 17, 2024 Jul 15, 2024
4 Insider transaction Jul 17, 2024 Jul 15, 2024
4 Insider transaction Jul 17, 2024 Jul 15, 2024
UPLOAD Letter from the SEC Jun 25, 2024 —
10-K/A Amended annual report Jun 14, 2024 Dec 31, 2023
10-Q/A Amended quarterly report Jun 14, 2024 Mar 31, 2024
CORRESP Letter to the SEC Jun 14, 2024 —
SC 13D/A Amended ownership over 5% (active) Jun 6, 2024 —
UPLOAD Letter from the SEC Jun 6, 2024 —
4 Insider transaction May 31, 2024 May 31, 2024
4 Insider transaction May 31, 2024 May 31, 2024
4 Insider transaction May 31, 2024 May 29, 2024
4 Insider transaction May 24, 2024 May 23, 2024
4 Insider transaction May 24, 2024 May 23, 2024
4 Insider transaction May 24, 2024 May 23, 2024
4 Insider transaction May 24, 2024 May 23, 2024
4 Insider transaction May 24, 2024 May 23, 2024
4 Insider transaction May 24, 2024 May 23, 2024
4 Insider transaction May 24, 2024 May 23, 2024
8-K Current report
Shareholder vote results, Other events
May 24, 2024 May 23, 2024
10-Q Quarterly report May 9, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 9, 2024 May 9, 2024
DEFA14A Additional proxy material Apr 12, 2024 —
DEF 14A Proxy statement Apr 12, 2024 May 23, 2024
ARS Annual report to shareholders Apr 12, 2024 Dec 31, 2023
4 Insider transaction Apr 10, 2024 Apr 8, 2024
SC 13D/A Amended ownership over 5% (active) Apr 10, 2024 —
SC 13D/A Amended ownership over 5% (active) Apr 1, 2024 —
4 Insider transaction Mar 26, 2024 Mar 22, 2024
10-K Annual report Mar 7, 2024 Dec 31, 2023
8-K Current report
Results of operations
Mar 7, 2024 Mar 7, 2024
8-K Current report
Other events
Feb 13, 2024 Feb 13, 2024
SC 13G/A Amended ownership over 5% (passive) Feb 12, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 9, 2024 —
3 Initial insider ownership Jan 26, 2024 Jan 24, 2024
SC 13G/A Amended ownership over 5% (passive) Jan 26, 2024 —
4 Insider transaction Jan 25, 2024 Jan 24, 2024
SC 13D/A Amended ownership over 5% (active) Jan 25, 2024 —
4 Insider transaction Jan 22, 2024 Jan 18, 2024
4 Insider transaction Jan 22, 2024 Jan 18, 2024
4 Insider transaction Jan 22, 2024 Jan 18, 2024
8-K Current report
Bylaw or fiscal year change
Dec 15, 2023 Dec 13, 2023
8-K Current report
Material agreement, New debt
Dec 14, 2023 Dec 14, 2023
8-K Current report
Other events
Dec 6, 2023 Dec 6, 2023
8-K Current report
Other events
Nov 28, 2023 Nov 28, 2023
4 Insider transaction Nov 21, 2023 Nov 20, 2023
EFFECT Filing Nov 17, 2023 —
CORRESP Letter to the SEC Nov 15, 2023 —
UPLOAD Letter from the SEC Nov 15, 2023 —
S-3 Shelf registration Nov 9, 2023 —
10-Q Quarterly report Nov 9, 2023 Sep 30, 2023
8-K Current report
Results of operations
Nov 9, 2023 Nov 9, 2023
4 Insider transaction Nov 8, 2023 Nov 6, 2023
4 Insider transaction Nov 3, 2023 Nov 1, 2023
4 Insider transaction Nov 3, 2023 Nov 1, 2023
4 Insider transaction Nov 3, 2023 Nov 1, 2023
8-K Current report
Other events
Nov 1, 2023 Nov 1, 2023
8-K Current report
Other events
Oct 30, 2023 Oct 30, 2023
8-K Current report
Other events
Sep 26, 2023 Sep 26, 2023
8-K Current report
Other events
Aug 21, 2023 Aug 21, 2023
8-K Current report
Results of operations
Aug 10, 2023 Aug 10, 2023
10-Q Quarterly report Aug 10, 2023 Jun 30, 2023

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
PHAT (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Florham Park, NJ
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1783183

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.